These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32869173)

  • 21. Tolvaptan corrects hyponatremia and relieves the burden of fluid/dietary restriction and hospitalization in hyponatremic patients with terminal lung cancer: a report of two cases.
    Kai K; Tominaga N; Koitabashi K; Ichikawa D; Shibagaki Y
    CEN Case Rep; 2019 May; 8(2):112-118. PubMed ID: 30637666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan.
    Petereit C; Zaba O; Teber I; Lüders H; Grohé C
    BMC Pulm Med; 2013 Aug; 13():55. PubMed ID: 23987478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Experience of the Efficacy and Safety of Low-dose Tolvaptan Therapy in a UK Tertiary Oncology Setting.
    Chatzimavridou-Grigoriadou V; Al-Othman S; Brabant G; Kyriacou A; King J; Blackhall F; Trainer PJ; Higham CE
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4766-e4775. PubMed ID: 33693944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum and urine responses to the aquaretic agent tolvaptan in hospitalized hyponatremic patients.
    Vaghasiya RP; DeVita MV; Michelis MF
    Int Urol Nephrol; 2012 Jun; 44(3):865-71. PubMed ID: 21607553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relapsing Syndrome of Inappropriate Antidiuretic Hormone Production Responding to Tolvaptan Treatment in a Patient With a Micronodular Formation of the Posterior Pituitary Gland.
    Reinke LM; Seoudy AK; Gärtner F; Rohmann N; Schulte DM; Schreiber S; Jansen O; Laudes M
    Exp Clin Endocrinol Diabetes; 2023 Sep; 131(9):472-475. PubMed ID: 37364592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-patient Tolvaptan use in SIADH: care audit, therapy observation and outcome analysis.
    Humayun MA; Cranston IC
    BMC Endocr Disord; 2017 Nov; 17(1):69. PubMed ID: 29110656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SIADH with Severe Hyponatremia in an Elderly Man with Herpes Zoster Infection: A Causal or Casual Association?
    Foppiani L
    Intern Med; 2018 Dec; 57(23):3393-3398. PubMed ID: 29984775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hyponatremia in older persons (II)-A clear treatment : How to detect tricks and avoid pitfalls].
    Hofmann W; Flägel K; Gosch M
    Z Gerontol Geriatr; 2020 Aug; 53(5):463-472. PubMed ID: 32691149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative Safety and Effectiveness of Urea and Tolvaptan for the Management of Hyponatremia.
    Scalla PA; Palma SM; Dittmar E; Zamora FJ; Trimino E
    J Pharm Pract; 2024 Dec; 37(6):1252-1257. PubMed ID: 38652561
    [No Abstract]   [Full Text] [Related]  

  • 30. Syndrome of inappropriate secretion of anti-diuretic hormone due to hypothalamic hamartoma: use of tolvaptan.
    Moon RJ; Soliman M; Hoogenboom L; Gilbert RD; Bird-Lieberman G; Singh J; Bockenhauer D; Kumaran A
    J Pediatr Endocrinol Metab; 2023 Sep; 36(9):895-899. PubMed ID: 37327191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tolvaptan resistance is related with a short-term poor prognosis in patients with lung cancer and syndrome of inappropriate anti-diuresis.
    Lacquaniti A; Campo S; Russo A; Adamo V; Monardo P
    G Ital Nefrol; 2023 Feb; 40(1):. PubMed ID: 36883921
    [No Abstract]   [Full Text] [Related]  

  • 32. [Lower doses of tolvaptan in hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion].
    Sánchez Sobrino P; Fernández Catalina P; Lorenzo Solar M; Rego Iraeta A
    Med Clin (Barc); 2015 Aug; 145(3):138-9. PubMed ID: 25543222
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical experience with Tolvaptan outpatient use. Cost and effectiveness in 9 cases.
    Barajas-Galindo DE; Vidal-Casariego A; Gómez-Hoyos E; Guerra-González M
    Gac Med Mex; 2020; 156(1):78-81. PubMed ID: 32026886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute hyponatremia after aneurysmal subarachnoid hemorrhage: Frequency, treatment, and outcome.
    Kieninger M; Kerscher C; Bründl E; Bele S; Proescholdt M; Zeman F; Graf B; Schmidt NO; Schebesch KM
    J Clin Neurosci; 2021 Jun; 88():237-242. PubMed ID: 33992191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of tolvaptan treatment between patients with the SIADH and congestive heart failure: a single-center experience.
    Park GH; Lee CM; Song JW; Jung MC; Kim JK; Song YR; Kim HJ; Kim SG
    Korean J Intern Med; 2018 May; 33(3):561-567. PubMed ID: 28286940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The use of tolvaptan in a case of severe hyponatriemia in SIADH during meningitis].
    Rollino C; Balbiano R; Caramello P; Roccatello D
    G Ital Nefrol; 2013; 30(6):. PubMed ID: 24402662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolvaptan Treatment in Children with Chronic Hyponatremia due to Inappropriate Antidiuretic Hormone Secretion: A Report of Three Cases.
    Tuli G; Tessaris D; Einaudi S; De Sanctis L; Matarazzo P
    J Clin Res Pediatr Endocrinol; 2017 Sep; 9(3):288-292. PubMed ID: 28515029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-life experience of tolvaptan use in the treatment of severe hyponatraemia due to syndrome of inappropriate antidiuretic hormone secretion.
    Tzoulis P; Waung JA; Bagkeris E; Carr H; Khoo B; Cohen M; Bouloux PM
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):620-6. PubMed ID: 26385871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Practical issues for the management of hyponatremia in oncology.
    Berardi R; Antonuzzo A; Blasi L; Buosi R; Lorusso V; Migliorino MR; Montesarchio V; Zilembo N; Sabbatini R; Peri A
    Endocrine; 2018 Jul; 61(1):158-164. PubMed ID: 29417373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real-World, Non-Interventional, Retrospective Study (SAMPLE) of Tolvaptan in Patients with Hyponatraemia Secondary to the Syndrome of Inappropriate Antidiuretic Hormone Secretion.
    Pose-Reino A; Runkle de la Vega I; de Jong-Laird A; Kabra M; Lindner U
    Adv Ther; 2021 Feb; 38(2):1055-1067. PubMed ID: 33306187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.